Search research articles
Contact Us
Filters
Showing results (291-300 of 688) with videos related to
Page
of 69
Sort By:
European Journal of Heart Failure
|
October 2, 2015
Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative
Thomas G von Lueder, Nicolas Girerd, Dan Atar, et al.
Journal of the American Heart Association
|
June 6, 2024
Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease
Ixchel Lima Posada, Matthieu Soulié, Yohan Stephan, et al.
European Heart Journal
|
December 8, 2022
Prevention of cardiorenal damage: importance of albuminuria
Luis M Ruilope, Alberto Ortiz, Alejandro Lucia, et al.
Journal of the American College of Cardiology
|
January 18, 2006
Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level
Barry E Bleske, John M Nicklas, Robert L Bard, et al.
Lancet (London, England)
|
December 11, 2012
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial
Michael A Weber, Kenneth Jamerson, George L Bakris, et al.
European Journal of Heart Failure
|
April 7, 2011
Neurohumoral effects of aliskiren in patients with symptomatic heart failure receiving a mineralocorticoid receptor antagonist: the Aliskiren Observation of Heart Failure Treatment study
Bertram Pitt, Roberto Latini, Aldo P Maggioni, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
May 6, 2021
Diuretic therapy as prognostic enrichment factor for clinical trials in patients with heart failure with reduced ejection fraction
Stefano Coiro, Nicolas Girerd, John J V McMurray, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
April 7, 2019
Mean BMI, visit-to-visit BMI variability and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and/or heart failure: insights from the High-Risk Myocardial Infarction Initiative
Susan Stienen, João Pedro Ferreira, Nicolas Girerd, et al.
American Journal of Nephrology
|
October 31, 2019
Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial
Luis M Ruilope, Rajiv Agarwal, Stefan D Anker, et al.
Journal of Hypertension
|
September 19, 2014
Reversibility of left ventricular mechanical dysfunction in patients with hypertensive heart disease
Susan Cheng, Amil M Shah, Juan Pablo Albisu, et al.
Page
of 69
Search research articles
Search
Showing results (291-300 of 688) with videos related to
Sort By:
Page
of 69
European Journal of Heart Failure
|
October 2, 2015
Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative
Thomas G von Lueder, Nicolas Girerd, Dan Atar, et al.
Journal of the American Heart Association
|
June 6, 2024
Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease
Ixchel Lima Posada, Matthieu Soulié, Yohan Stephan, et al.
European Heart Journal
|
December 8, 2022
Prevention of cardiorenal damage: importance of albuminuria
Luis M Ruilope, Alberto Ortiz, Alejandro Lucia, et al.
Journal of the American College of Cardiology
|
January 18, 2006
Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level
Barry E Bleske, John M Nicklas, Robert L Bard, et al.
Lancet (London, England)
|
December 11, 2012
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial
Michael A Weber, Kenneth Jamerson, George L Bakris, et al.
European Journal of Heart Failure
|
April 7, 2011
Neurohumoral effects of aliskiren in patients with symptomatic heart failure receiving a mineralocorticoid receptor antagonist: the Aliskiren Observation of Heart Failure Treatment study
Bertram Pitt, Roberto Latini, Aldo P Maggioni, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
May 6, 2021
Diuretic therapy as prognostic enrichment factor for clinical trials in patients with heart failure with reduced ejection fraction
Stefano Coiro, Nicolas Girerd, John J V McMurray, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
April 7, 2019
Mean BMI, visit-to-visit BMI variability and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and/or heart failure: insights from the High-Risk Myocardial Infarction Initiative
Susan Stienen, João Pedro Ferreira, Nicolas Girerd, et al.
American Journal of Nephrology
|
October 31, 2019
Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial
Luis M Ruilope, Rajiv Agarwal, Stefan D Anker, et al.
Journal of Hypertension
|
September 19, 2014
Reversibility of left ventricular mechanical dysfunction in patients with hypertensive heart disease
Susan Cheng, Amil M Shah, Juan Pablo Albisu, et al.
Page
of 69